Epigenetic gene silencing in cancer: the DNA hypermethylome
Open accessThe DOI matches its Crossref record; 99 of the 104 references it cites were found in a registry or an index.
Abstract
Epigenetic gene inactivation in transformed cells involves many 'belts of silencing'. One of the best-known lesions of the malignant cell is the transcriptional repression of tumor-suppressor genes by promoter CpG island hypermethylation. We are in the process of completing the molecular dissection of the entire epigenetic machinery involved in methylation-associated silencing, such as DNA methyltransferases, methyl-CpG binding domain proteins, histone deacetylases, histone methyltransferases, histone demethylases and Polycomb proteins. The first indications are also starting to emerge about how the combination of cellular selection and targeted pathways leads to abnormal DNA methylation. One thing is certain already, promoter CpG island hypermethylation of tumor-suppressor genes is a common hallmark of all human cancers. It affects all cellular pathways with a tumor-type specific profile, and in addition to classical tumor-suppressor and DNA repair genes, it includes genes involved in premature aging and microRNAs with growth inhibitory functions. The importance of hypermethylation events is already in evidence at the bedside of cancer patients in the form of cancer detection markers and chemotherapy predictors, and in the approval of epigenetic drugs for the treatment of hematological malignancies. In the very near future, the synergy of candidate gene approaches and large-scale epigenomic technologies, such as methyl-DIP, will yield the complete DNA hypermethylome of cancer cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly, the epigenetic landscape of human malignancies exhibits massive reprogramming in their DNA methylation patterns.”
From Meta-hallmarks of aging and cancer (2023) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756
MicroRNA expression profiles classify human cancers
Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,539
MicroRNA signatures in human cancers
Calin, G. A., & Croce, C. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1997 · Cited by 7,590
MicroRNAs: small RNAs with a big role in gene regulation
He, L., & Hannon, G. J. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1379 · Cited by 7,118
Okano, M., Bell, D. W., Haber, D. A., & Li, E. (1999) · Cell · doi:10.1016/s0092-8674(00)81656-6 · Cited by 6,143
A bivalent chromatin structure marks key developmental genes in embryonic stem cells
Bernstein, B. E., Mikkelsen, T. S., Xie, X., Kamal, M., Huebert, D. J., Cuff, J., Fry, B., Meissner, A., Wernig, M., Plath, K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.02.041 · Cited by 5,361
CpG-rich islands and the function of DNA methylation
Bird, A. P. (1986) · Nature · doi:10.1038/321209a0 · Cited by 3,777
RAS Is Regulated by the let-7 MicroRNA Family
Johnson, S. M., Grosshans, H., Shingara, J., Byrom, M., Jarvis, R., Cheng, A., Labourier, E., Reinert, K. L., Brown, D., & Slack, F. J. (2005) · Cell · doi:10.1016/j.cell.2005.01.014 · Cited by 3,656
Epigenetic differences arise during the lifetime of monozygotic twins
Fraga, M. F., Ballestar, E., Paz, M. F., Ropero, S., Setien, F., Ballestar, M. L., Heine-Suñer, D., Cigudosa, J. C., Urioste, M., Benitez, J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500398102 · Cited by 3,602
Self-citationmiR-15 and miR-16 induce apoptosis by targeting BCL2
Cimmino, A., Calin, G. A., Fabbri, M., Iorio, M. V., Ferracin, M., Shimizu, M., Wojcik, S. E., Aqeilan, R. I., Zupo, S., Dono, M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506654102 · Cited by 3,517
Cited by
Epigenetic modifications and human disease
Portela, A., & Esteller, M. (2010) · Nature Biotechnology · doi:10.1038/nbt.1685 · Cited by 2,836
“MBD family members in turn recruit histone-modifying and chromatin-remodeling complexes to methylated site”
BackgroundHoeijmakers, J. H. J. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804615 · Cited by 2,239
Emerging landscape of oncogenic signatures across human cancers
Ciriello, G., Miller, M. L., Aksoy, B. A., Senbabaoglu, Y., Schultz, N., & Sander, C. (2013) · Nature Genetics · doi:10.1038/ng.2762 · Cited by 1,378
Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers
Okugawa, Y., Grady, W. M., & Goel, A. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.07.011 · Cited by 782
Kidney fibrosis: from mechanisms to therapeutic medicines
Huang, R., Fu, P., & Ma, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01379-7 · Cited by 781
“DNA methylation DNA methylation is a reaction by adding a methyl group to carbon 5 position of the cytosine residue (CpG site) which is catalyzed by DNA methyltransferases (DNMTs), usually contributing to the loss of gene expression.(170) Hypomethylation or DNA methylation on specific CpG site exert key functions in k…”
BackgroundDNA methylation profiling in the clinic: applications and challenges
Heyn, H., & Esteller, M. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3270 · Cited by 746
Review of cancer from perspective of molecular
Hassanpour, S. H., & Dehghani, M. (2017) · Journal of Cancer Research and Practice · doi:10.1016/j.jcrpr.2017.07.001 · Cited by 683
“These events have a pivotal role in the induction of cancer ((42)).”
BackgroundMedicinal Plants: Their Use in Anticancer Treatment.
Greenwell, M., & Rahman, P. K. S. M. (2015) · International Journal of Pharmaceutical Sciences and Research · doi:10.13040/ijpsr.0975-8232.6(10).4103-12 · Cited by 696
“Int J Pharm Sci Res 2015; 6(10): 4103-12.”
BackgroundMeta-hallmarks of aging and cancer
López-Otín, C., Pietrocola, F., Roiz-Valle, D., Galluzzi, L., & Kroemer, G. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2022.11.001 · Cited by 529
Epigenetic modifications in cancer
Kanwal, R., & Gupta, S. (2012) · Clinical Genetics · doi:10.1111/j.1399-0004.2011.01809.x · Cited by 550
“This provides tumor cells with a growth advantage and increases their genetic instability and aggressiveness (22, 30).”
BackgroundLarge non-coding RNAs: missing links in cancer?
Huarte, M., & Rinn, J. L. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq353 · Cited by 484
Epigenetic regulation of microRNA expression in colorectal cancer
Bandres, E., Agirre, X., Bitarte, N., Ramirez, N., Zarate, R., Roman‐Gomez, J., Prosper, F., & Garcia‐Foncillas, J. (2009) · International Journal of Cancer · doi:10.1002/ijc.24638 · Cited by 439
“region of genes is an important mechanism of gene regulation, aberrant hypermethylation of tumor suppressor genes plays a significant role in tumor development.(17) In fact downregulation of tumor suppressor genes in human cancer has been tightly linked to the presence of CpG island promoter hypermethylation(18,19) an…”
BackgroundThe emerging role of epigenetic therapeutics in immuno-oncology
Topper, M. J., Vaz, M., Marrone, K. A., Brahmer, J. R., & Baylin, S. B. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0266-5 · Cited by 433
Epigenetics in cancer stem cells
Toh, T. B., Lim, J. J., & Chow, E. K.-H. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0596-9 · Cited by 422
“DNA hypermethylation has also been associated with the silencing of tumor suppressor genes as well as differentiation genes in various cancers [30].”
BackgroundTumor initiation and early tumorigenesis: molecular mechanisms and interventional targets
Zhang, S., Xiao, X., Yi, Y., Wang, X., Zhu, L., Shen, Y., Lin, D., & Wu, C. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01848-7 · Cited by 399
“92 Additionally, hypermethylation of promoter CpG islands is frequently observed in lineage-speci fi c transcription factor (TF) sequences that carry bivalent H3K4me3 and H3K27me3 modi fi cations, transforming these previously poised sequences into inactive states that promote dedifferentiation and…”
BackgroundPan-Cancer Landscape of Aberrant DNA Methylation across Human Tumors
Saghafinia, S., Mina, M., Riggi, N., Hanahan, D., & Ciriello, G. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.09.082 · Cited by 357
“, 2015), and (2) identification of mRNA silencing of genes of interest by hyper-methylation (Esteller, 2007; Cancer Genome Atlas Research Network, 2012).”
InfluentialEpigenetic drivers of tumourigenesis and cancer metastasis
Chatterjee, A., Rodger, E. J., & Eccles, M. R. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.08.004 · Cited by 328
DNA polymerases and human disease
Loeb, L. A., & Monnat, R. J. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2345 · Cited by 320
DNA methylomes, histone codes and miRNAs: Tying it all together
Guil, S., & Esteller, M. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.09.005 · Cited by 317
Fetahu, I. S., Höbaus, J., & Kállay, E. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00164 · Cited by 313
Epigenetic codes in cognition and behaviour
Gräff, J., & Mansuy, I. M. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.01.021 · Cited by 309
“Cancer Epigenetic mechanisms, specifically DNA methylation, are idely recognized to be a major factor in the etiology of varous types of cancer (for a review see [136]).”
BackgroundGlioma CpG island methylator phenotype (G-CIMP): biological and clinical implications
Malta, T. M., de Souza, C. F., Sabedot, T. S., Silva, T. C., Mosella, M. S., Kalkanis, S. N., Snyder, J., Castro, A. V. B., & Noushmehr, H. (2018) · Neuro-Oncology · doi:10.1093/neuonc/nox183 · Cited by 302
Molecular biomarkers in acute myeloid leukemia
Prada-Arismendy, J., Arroyave, J. C., & Röthlisberger, S. (2017) · Blood Reviews · doi:10.1016/j.blre.2016.08.005 · Cited by 304
Epigenetic principles and mechanisms underlying nervous system functions in health and disease
MEHLER, M. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.10.001 · Cited by 291
“Mutations in genes encoding epigenetic modifying machinery (HDACs, nucleosome assembly factors and histone chaperones) are also seen in gliomas and may predict responses to certain classes of epigenetic therapeutic agents (Esteller, 2007a; 2008; Hesson et al., 2004; Kim et al., 2006b).”
BackgroundInfluentialThe Global Breast Cancer Burden
Benson, J. R., & Jatoi, I. (2012) · Future Oncology · doi:10.2217/fon.12.61 · Cited by 274
Datta, J., Ghoshal, K., Denny, W. A., Gamage, S. A., Brooke, D. G., Phiasivongsa, P., Redkar, S., & Jacob, S. T. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3669 · Cited by 270
RetractedNakada, C., Matsuura, K., Tsukamoto, Y., Tanigawa, M., Yoshimoto, T., Narimatsu, T., Nguyen, L., Hijiya, N., Uchida, T., Sato, F., et al. (2008) · The Journal of Pathology · doi:10.1002/path.2437 · Cited by 269
Aberrant chromatin at genes encoding stem cell regulators in human mixed-lineage leukemia
Guenther, M. G., Lawton, L. N., Rozovskaia, T., Frampton, G. M., Levine, S. S., Volkert, T. L., Croce, C. M., Nakamura, T., Canaani, E., & Young, R. A. (2008) · Genes & Development · doi:10.1101/gad.1741408 · Cited by 270
“Unlike “genetic lesions” that involve changes in genome sequence in disease cells, “epigenetic lesions” include changes to histone modification states, DNA methylation states, or distribution of chromatin-modifying enzymes (Esteller 2007; Feinberg 2007).”
BackgroundThe LATS1 and LATS2 tumor suppressors: beyond the Hippo pathway
Furth, N., & Aylon, Y. (2017) · Cell Death & Differentiation · doi:10.1038/cdd.2017.99 · Cited by 260
“Promoter hypermethylation is another mechanism by which tumor suppressors are often inactivated.(70) Such mode of inactivation has been documented for LATS1, LATS2,(74,75) and in some cases for both, in various types of tumors.”
BackgroundRising from the RecQ-age: the role of human RecQ helicases in genome maintenance
BOHR, V (2008) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2008.09.003 · Cited by 257
“RECQ1-deficient mice have been constructed and they seem to be normal, but mouse embryonic fibroblasts from these mice display genomic instability [27].”
BackgroundLee, J. H., Khor, T. O., Shu, L., Su, Z.-Y., Fuentes, F., & Kong, A.-N. T. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.09.008 · Cited by 247
“The effect of miRNAs on epigenetic mechanisms and the mutual epigenetic regulations of miRNA expression appear to occur during carcinogenesis (Jones & Baylin, 2002; Esteller, 2007; Kai & Pasquinelli, 2010).”
BackgroundProspects for epigenetic epidemiology
Foley, D. L., Craig, J. M., Morley, R., Olsson, C. J., Dwyer, T., Smith, K., & Saffery, R. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn380 · Cited by 244
“The increase in tumor suppressor gene CpG island methylation between cancerous and noncancerous tissue is often close to 100% (77) and is usually reversed at CpG sites associated with tandemly repetitive and interspersed repeat DNA in the same tumor cells (78–81).”
Csoka, A. B., & Szyf, M. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2008.10.039 · Cited by 241
“Below we evaluate the evidence for this hypothesis, and discuss the consequences for modern medicine should it prove to be correct.”
BackgroundRoles of Werner syndrome protein in protection of genome integrity
Rossi, M. L., Ghosh, A. K., & Bohr, V. A. (2010) · DNA Repair · doi:10.1016/j.dnarep.2009.12.011 · Cited by 227
“Epigenetic regulation, specifically hypermethylation of tumor suppressor genes, is tightly linked with cancer [44].”
BackgroundDNA hypomethylation in the origin and pathogenesis of human diseases
Pogribny, I. P., & Beland, F. A. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0015-5 · Cited by 220
“This list is noticeably shorter than the number of hypermethylated genes in human cancers [153] and even in any specific type of cancer, e.”
BackgroundMethyl-DNA Immunoprecipitation (MeDIP): Hunting down the DNA Methylome
Jacinto, F. V., Ballestar, E., & Esteller, M. (2008) · BioTechniques · doi:10.2144/000112708 · Cited by 214
“gene inactivation that complements genetic lesions (11).”
Epigenetic regulation of microRNAs in cancer: An integrated review of literature
Kunej, T., Godnic, I., Ferdin, J., Horvat, S., Dovc, P., & Calin, G. A. (2011) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2011.03.008 · Cited by 205
Cancer Chemoprevention and Nutri-Epigenetics: State of the Art and Future Challenges
Gerhauser, C. (2012) · Topics in Current Chemistry · doi:10.1007/128_2012_360 · Cited by 194
“RARb has been identified as silenced by promoter methylation in various tumor types, including colorectal, breast, prostate, head and neck, stomach, and liver cancer, and lymphoma (overview in [279]).”
BackgroundEnhancer selectivity in space and time: from enhancer–promoter interactions to promoter activation
Yang, J. H., & Hansen, A. S. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00710-6 · Cited by 191
Iacobuzio-Donahue, C. A. (2009) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.3.121806.151442 · Cited by 188
Asf1b, the necessary Asf1 isoform for proliferation, is predictive of outcome in breast cancer
Corpet, A., De Koning, L., Toedling, J., Savignoni, A., Berger, F., Lemaître, C., O'Sullivan, R. J., Karlseder, J., Barillot, E., Asselain, B., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2010.335 · Cited by 187
“We then assayed the ability of cells depleted of the different Asf1 isoforms to undergo ‘unlimited’ division by performing a colony formation assay (Franken et al, 2006) on mammary tumoral Hs578T cells transfected with control, Asf1a, Asf1b or Asf1(aþ b) siRNAs.”
MethodDworkin, A. M., Huang, T. H.-M., & Toland, A. E. (2009) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2009.02.007 · Cited by 171
Good guy or bad guy: the opposing roles of microRNA 125b in cancer
Banzhaf-Strathmann, J., & Edbauer, D. (2014) · Cell Communication and Signaling · doi:10.1186/1478-811x-12-30 · Cited by 169
“Promoter DNA methylation is known to be a rather specific event during carcinogenesis, since only selected genes are hypermethylated in a tumor cell [78].”
Position effects influence HIV latency reversal
Chen, H.-C., Martinez, J. P., Zorita, E., Meyerhans, A., & Filion, G. J. (2017) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3328 · Cited by 165
The clinical characteristics of Werner syndrome: molecular and biochemical diagnosis
Muftuoglu, M., Oshima, J., von Kobbe, C., Cheng, W.-H., Leistritz, D. F., & Bohr, V. A. (2008) · Human Genetics · doi:10.1007/s00439-008-0562-0 · Cited by 161
“The correlation between WRN methylation status and irinotecan response clearly needs to be independently conWrmed by other investigators, as numerous genes undergo methylation-associated changes in the tumors (Esteller 2007).”
DNA methylation-based biomarkers in bladder cancer
Kandimalla, R., van Tilborg, A. A., & Zwarthoff, E. C. (2013) · Nature Reviews Urology · doi:10.1038/nrurol.2013.89 · Cited by 173
Methylation of homeobox genes is a frequent and early epigenetic event in breast cancer
Tommasi, S., Karm, D. L., Wu, X., Yen, Y., & Pfeifer, G. P. (2009) · Breast Cancer Research · doi:10.1186/bcr2233 · Cited by 151
“Methylation of CpG-rich islands encompassing gene promoter regions is especially relevant for the silencing of important tumor suppressor genes and accounts for a growing number of diseases, including breast cancer [3-5].”
BackgroundThe effect of environmental chemicals on the tumor microenvironment
Casey, S. C., Vaccari, M., Al‐Mulla, F., Al-Temaimi, R. A., Amedei, A., Barcellos‐Hoff, M. H., Brown, D. G., Chapellier, M., Christopher, J., Curran, C. S., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv035 · Cited by 171
“Cancers display global hypomethylation combined with specific regions of hypermethylation within tumor suppressor gene promoter elements such as p16INK4a, hMLH1 and BRCA1 (31).”
BackgroundmiRNAs and cancer: An epigenetics view
Malumbres, M. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.06.005 · Cited by 167
“3.1 DNA methylation of miRNAs Approximately half of miRNA genes are associated with CpG islands and their expression can be therefore modulated by methylation (Esteller, 2007; Weber et al., 2007).”
BackgroundInfluentialKraus, T. F. J., Globisch, D., Wagner, M., Eigenbrod, S., Widmann, D., Münzel, M., Müller, M., Pfaffeneder, T., Hackner, B., Feiden, W., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27429 · Cited by 168
“Transcriptional inactivation caused by promoter hypermethylation affects genes involved in the main cellular pathways, DNA repair, vitamin response, Ras signaling, cell-cycle control, p53 network and apoptosis.(15) Hypermethylation patterns are tumor-type specific and it is still unclear why certain regions become hyp…”
BackgroundCpG Island Methylation in Colorectal Cancer: Past, Present and Future
Curtin, K., Slattery, M. L., & Samowitz, W. S. (2011) · Pathology Research International · doi:10.4061/2011/902674 · Cited by 154
“Inactivation of particular genes may confer a growth advantage, resulting in clonal selection [72].”
BackgroundFrequent promoter hypermethylation of Wnt pathway inhibitor genes in malignant astrocytic gliomas
Götze, S., Wolter, M., Reifenberger, G., Müller, O., & Sievers, S. (2009) · International Journal of Cancer · doi:10.1002/ijc.24981 · Cited by 149
“In general, DNA methylation patterns have been found to be correlated with tumor type and prognosis of various cancers and may therefore be helpful as diagnostic or prognostic markers.(37,38) As stated above, hypermethylation of the MGMT promoter has been linked to favorable response to alkylating chemotherapy and pro…”
BackgroundEpigenetic regulation mechanisms of microRNA expression
Morales, S., Monzó, M., & Navarro, A. (2017) · BioMolecular Concepts · doi:10.1515/bmc-2017-0024 · Cited by 160
“CpGs are mostly unmethylated at the early stages of development, allowing the expression of a particular gene if the appropriate transcription factors are present and the chromatin structure is accessible (32).”
BackgroundA Novel Epigenetic Signature for Early Diagnosis in Lung Cancer
Díaz‐Lagares, Á., Méndez‐González, J., Hervás, D., Saigí, M., Pajares, M. J., Garcia, D., Crujerias, A. B., Pı́o, R., Montuenga, L. M., Zulueta, J. J., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2346 · Cited by 142
Huang, S. K., Fisher, A. S., Scruggs, A. M., White, E. S., Hogaboam, C. M., Richardson, B. C., & Peters-Golden, M. L. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100446 · Cited by 146
The role of vitamin D and VDR in carcinogenesis: Through epidemiology and basic sciences
Bandera-Merchán, B., Morcillo, S., Martín‐Núñez, G. M., Tinahones, F. J., & Macías‐González, M. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.11.020 · Cited by 145
Methylation across the central dogma in health and diseases: new therapeutic strategies
Liu, R., Zhao, E., Yu, H., Yuan, C., Abbas, M. N., & Cui, H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01528-y · Cited by 164
Chen, M.-L., Shen, F., Huang, W., Qi, J., Wang, Y., Feng, Y., Liu, S.-M., & Yuan, B. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2012.193938 · Cited by 137
Loss of 5-hydroxymethylcytosine in cancer: Cause or consequence?
Ficz, G., & Gribben, J. G. (2014) · Genomics · doi:10.1016/j.ygeno.2014.08.017 · Cited by 153
“Genomic hypomethylation is a key feature in cancer [1,2].”
DNA methylation in thyroid cancer
Zafón, C., Gil, J., Pérez-González, B., & Jordà, M. (2019) · Endocrine Related Cancer · doi:10.1530/erc-19-0093 · Cited by 150
Dietrich, D., Kneip, C., Raji, O., Liloglou, T., Seegebarth, A., Schlegel, T., Flemming, N., Rausch, S., Distler, J., Fleischhacker, M., et al. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1264 · Cited by 136
The Implications of Heterogeneous DNA Methylation for The Accurate Quantification of Methylation
Mikeska, T., Candiloro, I. L. M., & Dobrovic, A. (2010) · Epigenomics · doi:10.2217/epi.10.32 · Cited by 145
Cheung, H., Lee, T., Davis, A., Taft, D. H., Rennert, O. M., & Chan, W. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605505 · Cited by 124
DNA methylation directs microRNA biogenesis in mammalian cells
Glaich, O., Parikh, S., Bell, R. E., Mekahel, K., Donyo, M., Leader, Y., Shayevitch, R., Sheinboim, D., Yannai, S., Hollander, D., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13527-1 · Cited by 130
Human papillomaviruses in epigenetic regulations
Durzyńska, J., Leśniewicz, K., & Poręba, E. (2016) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2016.09.006 · Cited by 135
Ren, X., Yang, X., Cheng, B., Chen, X., Zhang, T., He, Q., Li, B., Li, Y., Tang, X.-R., Wen, X., et al. (2017) · Nature Communications · doi:10.1038/ncomms14053 · Cited by 123
“Epigenetic alterations are considered a hallmark of cancers because of their contribution to cancer initiation and progression 5,6 .”
An Epigenetic Role of Mitochondria in Cancer
Liu, Y., Chen, C., Wang, X., Sun, Y., Zhang, J., Chen, J., & Shi, Y. (2022) · Cells · doi:10.3390/cells11162518 · Cited by 141
“For example, DNA hypermethylation has been associated with the silencing of tumor suppressor genes as well as differentiation genes in various cancers [45].”
BackgroundEnhancer methylation dynamics contribute to cancer plasticity and patient mortalityPreprint
Bell, R. E., Golan, T., Sheinboim, D., Malcov, H., Amar, D., Salamon, A., Liron, T., Gelfman, S., Gabet, Y., Ron Shamir, A., et al. (2016) · Genome Research · doi:10.1101/gr.197194.115 · Cited by 126
Plant-derived epigenetic modulators for cancer treatment and prevention
Schnekenburger, M., Dicato, M. A., & Diederich, M. F. (2014) · Biotechnology Advances · doi:10.1016/j.biotechadv.2014.03.009 · Cited by 118
Integrated epigenomics identifies BMP4 as a modulator of cisplatin sensitivity in gastric cancer
Ivanova, T., Zouridis, H., Wu, Y., Cheng, L. L., Tan, I. B., Gopalakrishnan, V., Ooi, C.-H., Lee, J., Qin, L., Wu, J., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-301113 · Cited by 114
“We observed methylation of several genes previously reported as methylated in GC, including MGMT (YCC10, TMK1, Hs746T), MLH1 (IM95) and APC (all cell lines except AZ521 and Hs746T).(20) To validate the GoldenGate platform results, we performed bisulphite sequencing analysis on three genes exhibiting variable cell line…”
MethodA new era of long-read sequencing for cancer genomics
Sakamoto, Y., Sereewattanawoot, S., & Suzuki, A. (2019) · Journal of Human Genetics · doi:10.1038/s10038-019-0658-5 · Cited by 144
Polycomb Group (PcG) Proteins and Human Cancers: Multifaceted Functions and Therapeutic Implications
Wang, W. T., Qin, J., Voruganti, S., Nag, S. A., Zhou, J., & Zhang, R. (2015) · Medicinal Research Reviews · doi:10.1002/med.21358 · Cited by 126
miRNAs: Effectors of Environmental Influences on Gene Expression and Disease
Hudder, A., & NOVAK, R. F. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn033 · Cited by 123
“Several studies have identified alterations in methylation patterns in human cancers that result in changes in miRNA expression (Calin and Croce, 2007; Esteller, 2007; Weber et al., 2007).”
BackgroundMethylation biomarkers for early cancer detection and diagnosis: Current and future perspectives
Ibrahim, J., Peeters, M., Camp, G. V., & de Beeck, K. O. (2022) · European Journal of Cancer · doi:10.1016/j.ejca.2022.10.015 · Cited by 128
UHRF1‐mediated tumor suppressor gene inactivation in nonsmall cell lung cancer
Daskalos, A., Oleksiewicz, U., Filia, A., Nikolaidis, G., Xinarianos, G., Gosney, J. R., Malliri, A., Field, J. K., & Liloglou, T. (2010) · Cancer · doi:10.1002/cncr.25531 · Cited by 125
“Epigenetic silencing of tumor suppressor genes (TSGs) is a hallmark in human cancers affecting multiple cellular pathways, such as cell signaling, adhesion and invasion, cell cycle, angiogenesis, DNA repair and apoptosis.(1,2) Nonsmall cell lung carcinomas (NSCLCs) are no exception to this, with a plethora of TSG prom…”
BackgroundCancer epigenetics: above and beyond
Brait, M., & Sidransky, D. (2011) · Toxicology Mechanisms and Methods · doi:10.3109/15376516.2011.562671 · Cited by 115
“These two members of the DNMT family are found highly expressed in embryonic stem cells and down-regulated in differentiated cells (Esteller 2007).”
BackgroundEndocrine-disrupting chemicals in aquatic environment: what are the risks for fish gametes?
Carnevali, O., Santangeli, S., Forner-Piquer, I., Basili, D., & Maradonna, F. (2018) · Fish Physiology and Biochemistry · doi:10.1007/s10695-018-0507-z · Cited by 125
“In addition, it was shown that epigenetic mechanisms enable the communication between gene transcription and environment (Esteller 2007).”
Epigenomics of leukemia: from mechanisms to therapeutic applications
Florean, C., Schnekenburger, M., Grandjenette, C., Dicato, M. A., & Diederich, M. F. (2011) · Epigenomics · doi:10.2217/epi.11.73 · Cited by 115
H3.3K27M mutant proteins reprogram epigenome by sequestering the PRC2 complex to poised enhancers
Dong, F., Gan, H., Cheng, L., Lee, J., Zhou, H., Sarkaria, J. N., Daniels, D. J., & Zhang, Z. (2018) · eLife · doi:10.7554/elife.36696 · Cited by 112
“, 2003; Ehrlich, 2009), and yet DNA hypermethylation at the promoters of TSGs has been frequently reported in many cancer types (Baylin and Jones, 2011; Esteller, 2007; Struhl, 2014).”
BackgroundLarge-scale analysis of DFNA5 methylation reveals its potential as biomarker for breast cancer
Croes, L., Beyens, M., Fransén, E., Ibrahim, J., Berghe, W. V., Suls, A., Peeters, M., Pauwels, P., Camp, G. V., & de Beeck, K. O. (2018) · Clinical Epigenetics · doi:10.1186/s13148-018-0479-y · Cited by 107
Down-Regulation of DUSP6 Expression in Lung Cancer
Okudela, K., Yazawa, T., Woo, T., Sakaeda, M., Ishii, J., Mitsui, H., Shimoyamada, H., Sato, H., Tajiri, M., Ogawa, N., et al. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080489 · Cited by 118
Integrative DNA methylation and gene expression analysis in high-grade soft tissue sarcomas
Renner, M., Wolf, T. A., Meyer, H. V., Hartmann, W., Penzel, R., Ulrich, A. B., Lehner, B., Hovestadt, V., Czwan, E., Egerer, G., et al. (2013) · Genome biology · doi:10.1186/gb-2013-14-12-r137 · Cited by 106
“; licensee BioMed Central Commons Attribution License (http://creativec reproduction in any medium, provided the or functional characterization and diagnosis of cancer [4,5].”
BackgroundThe promise and failures of epigenetic therapies for cancer treatment
Bojang, P., & Ramos, K. S. (2013) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.05.009 · Cited by 107
GSDME and its role in cancer: From behind the scenes to the front of the stage
Schutter, E. D., Croes, L., Ibrahim, J., Pauwels, P., de Beeck, K. O., Vandenabeele, P., & Camp, G. V. (2020) · International Journal of Cancer · doi:10.1002/ijc.33390 · Cited by 108
“serve as a mechanism to inactivate tumor suppressor genes in cancer.(41,42) In this aspect, it was hypothesized that DNA promoter methylation of GSDME prevents GSDME-mediated regulated cell death”
BackgroundEpigenetic Therapy for the Treatment of Hypertension-Induced Cardiac Hypertrophy and Fibrosis
Watson, C. J., Horgan, S. J., Neary, R., Glezeva, N., Tea, I., Corrigan, N., McDonald, K., Ledwidge, M. T., & Baugh, J. A. (2015) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248415591698 · Cited by 99
Congenital Heart Disease: The Crossroads of Genetics, Epigenetics and Environment
Vecoli, C., Pulignani, S., Foffa, I., & Andreassi, M. G. (2014) · Current Genomics · doi:10.2174/1389202915666140716175634 · Cited by 112
“Altered methylation status has been widely described in carcinogenesis as a major mechanism of gene silencing [64].”
BackgroundHomeobox gene IRX1 is a tumor suppressor gene in gastric carcinoma
Guo, X., Liu, W., Pan, Y., Ni, P., Ji, J., Guo, L., Zhang, J., Wu, J., Jiang, J., Chen, X., et al. (2010) · Oncogene · doi:10.1038/onc.2010.143 · Cited by 97
Methylomics of gene expression in human monocytes
Liu, Y., Ding, J., Reynolds, L. M., Lohman, K., Register, T. C., de la Fuente, A., Howard, T. D., Hawkins, G., Cui, W., Morris, J., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt356 · Cited by 97
Epigenetics Offer New Horizons for Colorectal Cancer Prevention
Schnekenburger, M., & Diederich, M. F. (2012) · Current Colorectal Cancer Reports · doi:10.1007/s11888-011-0116-z · Cited by 98
“CGIs are usually unmethylated in normal differentiated cells, whereas CpGs located in intergenic regions are methylated [8, 15].”
BackgroundDNA Methylation Pattern as Important Epigenetic Criterion in Cancer
Fakhr, M. G., Hagh, M. F., Shanehbandi, D., & Baradaran, B. (2013) · Genetics Research International · doi:10.1155/2013/317569 · Cited by 109
Epigenetic signatures of invasive status in populations of marine invertebrates
Ardura, A., Zaiko, A., Morán, P., Planes, S., & García‐Vázquez, E. (2017) · Scientific Reports · doi:10.1038/srep42193 · Cited by 92
Downregulation of microRNA-362-3p and microRNA-329 promotes tumor progression in human breast cancer
Kang, H. T., Kim, C., Lee, H., Rho, J. G., Seo, J.-W., Nam, J.-W., Song, W. K., Nam, S. W., Kim, W. J., & Lee, E.-K. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2015.116 · Cited by 98
“tion control the expression of miR genes in various cancers.(24,25) To determine whether epigenetic regulation is”
BackgroundHematopoietic Stem Cell Development
Cullen, S. M., Mayle, A., Rossi, L., & Goodell, M. A. (2014) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/b978-0-12-416022-4.00002-0 · Cited by 109
Götze, S., Feldhaus, V., Traska, T., Wolter, M., Reifenberger, G., Tannapfel, A., Kuhnen, C., Martin, D., Müller, O., & Sievers, S. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-447 · Cited by 91
“DNA hypermethylation constitutes a major cause of aberrant gene silencing in cancer [28].”
BackgroundFrau, M., Tomasi, M. L., Simile, M. M., Demartis, M. I., Salis, F., Latte, G., Calvisi, D. F., Seddaiu, M. A., Daino, L., Feo, C. F., et al. (2012) · Hepatology · doi:10.1002/hep.25643 · Cited by 88
“Suppression of gene expression is frequently associated with methylated DNA and deacetylated histones, in a dense chromatin structure, whereas active transcription is associated with unmethylated DNA, hyperacetylated histones, in open chromatin.(40) According to recent results,(20) methylation of CCGG at 997 does not…”
BackgroundGlobal histone modification of histone H3 in colorectal cancer and its precursor lesions
Nakazawa, T., Kondo, T., Ma, D., Niu, D., Mochizuki, K., Kawasaki, T., Yamane, T., Iino, H., Fujii, H., & Katoh, R. (2011) · Human Pathology · doi:10.1016/j.humpath.2011.07.009 · Cited by 87
The DNA methylome of pediatric acute lymphoblastic leukemia
Davidsson, J., Lilljebjörn, H., Andersson, A., Veerla, S., Heldrup, J., Behrendtz, M., Fioretos, T., & Johansson, B. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp354 · Cited by 86
“It has previously been reported that the profiles of CpG island hypermethylation of tumor suppressor genes differ between different tumor entities (10) and that acute myeloid leukemia and ALL can be separated using a 57 gene/249 CpG methylation array (17).”
BackgroundKondo, T., Nakazawa, T., Ma, D., Niu, D., Mochizuki, K., Kawasaki, T., Nakamura, N., Yamane, T., Kobayashi, M., & Katoh, R. (2009) · Laboratory Investigation · doi:10.1038/labinvest.2009.50 · Cited by 86
“In addition to genetic aberrations, recent advances have further disclosed the significance of epigenetic events in the development and progression of human tumorigenesis.(5) Indeed, various tumor-suppressor genes and thyroid hormone-related genes are epigenetically silenced in thyroid tumors.”
BackgroundDigging deep into “dirty” drugs – modulation of the methylation machinery
Pleyer, L., & Greil, R. (2015) · Drug Metabolism Reviews · doi:10.3109/03602532.2014.995379 · Cited by 84
“HDACs are implicated in cancer through their aberrant recruitment and silencing of tumor suppressor genes.”
BackgroundInfluentialEpigenetics and epigenetic alterations in pancreatic cancer.
Omura, N., & Goggins, M. (2009) · PubMed · Cited by 100
Metadata
- Authors
- Esteller, M.
- Affiliations
- Spanish National Cancer Research Centre (ES)
- Corresponding author
- Esteller, Manel
- ORCID
- Esteller, Manel
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-04-15
- Volume
- 16
- Issue
- R1
- Pages
- R50-R59
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2158207797
- Cited by
- 725
- References
- 104
- Citations by year
- 2026: 12 · 2025: 24 · 2024: 17 · 2023: 34 · 2022: 35 · 2021: 29 · 2020: 17 · 2019: 35 · 2018: 38 · 2017: 44 · 2016: 45 · 2015: 56 · 2014: 36 · 2013: 56 · 2012: 62
- FWCI
- 3.66
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Human Molecular Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Syndromes and Imprinting
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer-related gene regulation
- Keywords
- epigenetic silencing, DNA hypermethylation, methylome, tumor suppressor, DNA methyltransferases, methyl-CpG binding domain proteins, histone deacetylase, histone methyltransferase, histone demethylase, Polycomb group proteins, DNA repair genes, microRNA, tumor markers, chemotherapy response prediction, epigenetic drugs, hematologic malignancies
- MeSH terms
- Werner Syndrome Helicase, Aging, Exodeoxyribonucleases, Humans, Neoplasms, RNA, Neoplasm, Werner Syndrome, Genes, Tumor Suppressor, CpG Islands, DNA Methylation, Gene Silencing, MicroRNAs, Epigenesis, Genetic, RecQ Helicases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.